Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea flag South Korea · Delayed Price · Currency is KRW
16,370
+20 (0.12%)
At close: Apr 29, 2026

Sam-A Pharm. Revenue

In the year 2025, Sam-A Pharm. had annual revenue of 77.80B KRW, down -18.60%. Sam-A Pharm. had revenue of 20.76B in the quarter ending December 31, 2025, with 5.81% growth.

Revenue
77.80B
Revenue Growth
-18.60%
P/S Ratio
1.28
Revenue / Employee
255.08M
Employees
300
Market Cap
99.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202577.80B-17.78B-18.60%
Dec 31, 202495.58B-1.63B-1.68%
Dec 31, 202397.21B15.51B18.99%
Dec 31, 202281.70B27.03B49.45%
Dec 31, 202154.67B1.01B1.89%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Daehan Nupharm 202.40B
Cosmax Nbt 287.48B
Ahn-Gook Pharmaceutical 306.87B
H.PIO 258.19B
Polaris AI Pharma 63.94B
Sinsin Pharmaceutical 113.78B
Samik Pharmaceutical Company LTD. 60.02B
GL Pharm Tech 35.27B
Revenue Rankings